Hacıeminoğlu Ülker Kübra, Tanrıverdi Çaycı Yeliz, Birinci Asuman
Department of Medical Microbiology, Ondokuz Mayıs University, Samsun, Türkiye.
Eur J Clin Microbiol Infect Dis. 2025 Apr 21. doi: 10.1007/s10096-025-05130-8.
Colistin is an antimicrobial used as a last resort in the treatment of resistant gram-negative infections associated with high morbidity and mortality. Therefore, the rapid and accurate detection of colistin susceptibility is of vital importance. However, the current methods used to determine colistin susceptibility face various challenges. The purpose of this study was to evaluate two novel rapid colistin susceptibility methods, namely resazurin-based rapid modified colistin disk elution (RrmCBDE) and nitrate reductase-based rapid modified colistin disk elution (NRrmCBDE), alongside the established modified colistin broth disk elution (mCBDE), against the reference broth microdilution (BMD) method for determining colistin susceptibility in Enterobacterales isolates.
The colistin susceptibility of 215 multidrug-resistant or extensively drug-resistant Enterobacterales isolates was determined using RrmCBDE and NRrmCBDE with 0.5 and 3 McFarland variations, and mCBDE test. The RrmCBDE and NRrmCBDE tests yielded results in approximately 6 h, whereas the mCBDE test required 16-20 h. The findings were then compared with the reference BMD method.
According to BMD results, the mCBDE method showed 98.6% categorical agreement (CA) with 1.39% very major errors (VME). It demonstrated 97.86% sensitivity and 100% specificity. For RrmCBDE, the 0.5 McFarland variation had 91.2% CA, 8.8% VME, 86.4% sensitivity, and 100% specificity, while the 3 McFarland variation achieved 97.2% CA, 2.79% VME, 95.7% sensitivity, and 100% specificity. Similarly, NRrmCBDE, the 0.5 McFarland variation exhibited 88.37% CA and 11.6% VME, 82.1% sensitivity, and 100% specificity, while the 3 McFarland variation demonstrated 98.6% CA, 1.39% VME, 97.86% sensitivity, and 100% specificity.
Based on these results, it was concluded that the novel RrmCBDE and NRrmCBDE tests, particularly with the 3 McFarland variation, provided results within approximately 6 h, making them a rapid alternative to conventional methods.
黏菌素是一种抗菌药物,用于治疗耐药革兰氏阴性菌感染的最后手段,此类感染具有高发病率和高死亡率。因此,快速准确地检测黏菌素敏感性至关重要。然而,目前用于确定黏菌素敏感性的方法面临各种挑战。本研究的目的是评估两种新型快速黏菌素敏感性检测方法,即基于刃天青的快速改良黏菌素纸片洗脱法(RrmCBDE)和基于硝酸还原酶的快速改良黏菌素纸片洗脱法(NRrmCBDE),并将其与既定的改良黏菌素肉汤纸片洗脱法(mCBDE),与参考肉汤微量稀释法(BMD)进行比较,以确定肠杆菌科分离株中的黏菌素敏感性。
使用RrmCBDE和NRrmCBDE,在0.5麦氏比浊度和3麦氏比浊度条件下,以及mCBDE试验,测定215株多重耐药或广泛耐药肠杆菌科分离株的黏菌素敏感性。RrmCBDE和NRrmCBDE试验大约6小时得出结果,而mCBDE试验需要16 - 20小时。然后将结果与参考BMD方法进行比较。
根据BMD结果,mCBDE方法显示出98.6%的绝对一致性(CA),1.39%的极重大误差(VME)。其敏感性为97.86%,特异性为100%。对于RrmCBDE,0.5麦氏比浊度条件下有91.2%的CA,8.8%的VME,86.4%的敏感性和100%的特异性,而3麦氏比浊度条件下达到97.2%的CA,2.79%的VME,95.7%的敏感性和100%的特异性。同样,对于NRrmCBDE,0.5麦氏比浊度条件下表现出88.37%的CA和11.6%的VME,82.1%的敏感性和100%的特异性,而3麦氏比浊度条件下显示出98.6%的CA,1.39%的VME,97.86%的敏感性和100%的特异性。
基于这些结果,得出结论:新型RrmCBDE和NRrmCBDE试验,特别是在3麦氏比浊度条件下,大约6小时内得出结果,使其成为传统方法的快速替代方法。